Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

ATTAIN-OA PAIN

Eli Lilly · Phase 3 · Active, not recruiting · Enrollment 800

NCT07153471

ArmPopulationDoseWeeksEstimandWeight change
Orforglipron (GZT1)Osteoarthritisn/r74n/rn/r
Placebo (GZT1)Osteoarthritisn/r74n/rn/r
Orforglipron (GZT2)Osteoarthritisn/r74n/rn/r
Placebo (GZT2)Osteoarthritisn/r74n/rn/r